German Remedies launches Novolizer

German Remedies, a part of the Zydus Cadila Group, has launched Novolizer - an inhaler for use by patients suffering from asthma and chornic obstructive pulmonary disease (COPD).

According to a release issued by Cadila to the BSE today, the technology for the device is provided by Sweden-based Meda Pharma along with exclusive rights to manufacture and market Novolizer in India.

"Novolizer is a third-generation refillable, breath-activated, multiple dose dry powder inhaler device, and can be used by patients suffering from asthma and COPD," the release added.